Author:
Bishay John H.,Park Eugene S.,Hemstreet George P.
Reference160 articles.
1. Alexandroff AB, Jackson AM, Skibinska A et al (1996) Production of IL-5, a classical TH2 cytokine, following bacillus calmette-guerin immunotherapy of bladder cancer. Int J Oncol 9:179–182
2. Arnold J, de Boer EC, O’Donnell MA et al (2004) Immunotherapy of experimental bladder cancer with recombinant BCG expressing interferon-gamma. J Immunother 27:116–123
3. Ayari C, Larue H, Hovington H et al (2009) Bladder tumor infiltrating mature dendritic cells and macrophages as predictors of response to bacillus calmette-guerin immunotherapy. Eur Urol 55(6):1386–1395
4. Badalament RA, Herr HW, Wong GY et al (1987) A prospective randomized trial of maintenance versus nonmaintenance intravesical bacillus calmette-guerin therapy of superficial bladder cancer. J Clin Oncol 5:441–449
5. Bartoletti R, Cai T, Gacci M et al (2005) Intravesical gemcitabine therapy for superficial transitional cell carcinoma: results of a phase II prospective multicenter study. Urology 66:726–731
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献